Resistance to Abemaciclib Is Associated with Increased Metastatic Potential and Lysosomal Protein Deregulation in Breast Cancer Cells

Using estrogen receptor positive breast cancer cell models, researchers showed that acquired resistance to abemaciclib was accompanied by increase in metastatic potential.